"Varied Viral Clearance Times in Immunocompromised COVID Patients: A Study Analysis"
Two new studies reveal that immune-compromised patients, such as those with cancer and HIV, exhibit varying times for clearing the COVID-19 virus, with some at higher risk for persistent infections. The studies found that patients with severe immunosuppression were more likely to have prolonged infections, while those with mild to moderate immunosuppression, including those on B-cell depleting therapy, were able to clear the virus during the acute phase of infection. The research also suggests that immunocompromised patients with persistent viruses may not be a significant source of mutated variants.